p38 MAPK activity is associated with mild and severe stages of AD, whereas extracellular regulated kinases’ (ERK1/2) activities are altered at all the stages of this disease, including stages with limited pathological signs [5]. Here, MAPK3 is linked to Alzheimer disease.